Cary J. Reich

Part of Amring Pharmaceuticals, Inc., Visant Medical, Inc. is a clinical-stage medical device company based in Menlo Park, CA. Symatese SAS, a French company based in Lyon, was instrumental in the development of Lacrifill, significantly enhancing the product's design and performance, by leveraging its expertise in tissue regeneration, reconstruction, and related delivery systems. The company received FDA 510 (k) clearance in 2022 for Lacrifill® cross-linked hyaluronic acid-based canalicular occlusive device, which is intended to block tear drainage by occlusion of the canalicular system. The device is indicated for use, for up to 6 months, in patients experiencing dry eye symptoms. The company specializes in injectable crosslinked HA gels for many markets, including aesthetic, rheumatology, and ophthalmology. Symatese designs the most advanced medical device solutions thanks to their technology portfolio in hyaluronic acid, collagen, thermoplastics, and silicone. The company was founded by Cary J. Reich and Vartan E. Ghazarossian. Vartan E. Ghazarossian has been the CEO since incorporation. Visant Medical was acquired by Amring Pharmaceuticals, Inc. on December 18, 2023.